Expression of toll-like receptor 9 in horse lungs

Anatomical Record

Volumn 292, Issue 7, 2009, Pages 1068-1077

  Schneberger, David ^a   Caldwell, Sarah ^a   Suri, Sarabjeet Singh ^a   Singh, Baljit ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Gadolinium chloride; Immuno gold EM; Immunohistochemistry; Lungs; PIM; TLR9

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HORSE; IMMUNE RESPONSE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHI; ENDOTHELIAL CELLS; GADOLINIUM; HORSES; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MICROSCOPY, IMMUNOELECTRON; PNEUMONIA; PULMONARY ARTERY; RESPIRATORY MUCOSA; RNA, MESSENGER; TOLL-LIKE RECEPTOR 9; UP-REGULATION;

BACTERIA (MICROORGANISMS); EQUIDAE;

EID: 70249151407     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20927     Document Type: Article

References (48)

1. An H, Xu H, Yu Y, Zhang M, Qi R, Yan X, Liu S, Wang W, Guo Z, Qin Z, Cao X. 2002. Up-regulation of TLR9 gene expression byLPS in mouse macrophages via activation of NF-kB, ERK and p38 MAPK signal pathways. Immunol Lett 81:165-169.
2. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Ex Med 202:1715-1724.
3. Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL. 2007 Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads t reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 37:3582-3586.
4. Berndt A, Derksen FJ, Venta PJ, Ewart S, Yuzbasiyan-Gurkan V, Robinson NE. 2007. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. Am J Lung Cell Mol Physiol 292:L936-L943.
5. Bhan U, Trujillo G, Lyn-Kew K, Newstead MW, Zeng X, Hogaboam CM, Krieg AM, Standiford TJ. 2008. TLR9 regulates lung macrophage phenotype and host immunity in murine Legionella pneumonia. Infect Immun 76:2895-2904.
6. Chen L, Arora M, Yarlagadda M, Oriss TB, Krishnamoorthy N, Ray A, Ray P. 2006. Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide. J Immunol 177:2373-2383.
7. Chitko-McKown CG, Chapes SK, Brown RE, Phillips RD, McKown RD, Blecha F. 1991. Porcine alveolar and pulmonary intravascular macrophages: comparison of immune functions. J Leukoc Biol 50:364-372.
8. Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG. 2006. Different roles for human lung dendritic cell subsets in pulmonary immune defense. Am J Respir Cell Mol Biol 35:387-393.
9. Dorn A, Kippenberger S. 2008. Clinical application of CpG-, non CpG-, and antisense oligodeoxynucleotides as immunomodulators. Curr Opin Mol Ther 10:10-20.
10. Eaton-Bassrir A, Dillon SB, Cunningham M, Rycyzyn MA, Mills J, Sarisky RT, Mbow ML. 2004. Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect Immun 72:7202-7211.
11. Ewaschuk JB, Backer JL, Churchill TA, Obermeier F, Krause DO, Madsen KL. 2007. Surface expression of toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun 75:2572-2579.
12. Fernandez S, Jose P, Avdiushko MG, Kaplan AM, Cohen DA. 2004. Inhibition of IL-10 receptor function in alveolar macrophages by toll-like receptor agonists. J Immunol 172:2613-2620.
13. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. 2000. A toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
14. Hu Z, Sun S, Zhou F. 2003. The binding of CpG-oligodeoxynucleotides to cell-surface and its immunostimulatory activity are modulated by extracellular acidic pH. Vaccine 21:485-490.
15. Jözsef L, Khreiss T, Filep JG. 2004. CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J 18:1776-1778.
16. Kalis C, Gumenscheimer M, Freudenberg N, Tchaptchet S, Fejer G, Heidt A, Akira S, Galanos C, Freudenberg MA. 2005. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 174:4295-4300.
17. Kitagaki K, Businga TR, Kline JN. 2006. Oral administration of CpG- ODN suppresses antigen-induced asthma in mice. Clin Exp Immunol 143:249-259.
18. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 160:2555-2559.
19. Knuefermann P, Baumgarten G, Koch A, Schwederski M, Velten M, Ehrentraut H, Mersmann J, Meyer R, Hoeft A, Zacharowski K, Grohé C. 2007. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo. Resp Res 8:72-80.
20. Krieg AM. 2002. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760.
21. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:6546-6549.
22. Kuramoto E, Yano O, Kimura Y, Baba M, Makino T, Yamamoto S, Yamamoto T, Kataoka T, Tokunaga T. 1992. Oligonucleotide sequences required for natural killer cell activation. Jpn Cancer Res 83:1128-1131.
23. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT. 2004. TLR9 signals after translocation from the ER to CpG DNA in the lysosome. Nat Immunol 5:190-198.
24. Li J, Ma Z, Tang Z-L, Stevens T, Pitt B, Li S. 2004. CpG DNA-mediated immune response in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 287:L552-L558.
25. Macfarlane DE, Manzel L. 1998. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J Immunol 160:1122-1131.
26. Morris DD. 1991. Endotoxemia in horses: a review of cellular and humoral mediators involved in its pathogenesis. J Vet Int Med 5:167-181.
27. O'Mahony DS, Pham U, Iver R, Hawn TR, Liles WC. 2008. Differential constitutive and cytokine-modulated expression of human toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci 5:1-8.
28. Parbhakar OP, Duke T, Townsend HG, Singh B. 2004. Immunophenotypic characterization and depletion of pulmonary intravascular macrophages of horses. Vet Res 35:39-51.
29. Parbhakar OP, Duke T, Townsend HG, Singh B. 2005. Depletion of pulmonary intravascular macrophages partially inhibits lipopolysaccharide-induced lung inflammation in horses. Vet Res 36:557-569.
30. Parilla NW, Hughes VS, Lierl KM, Wong HR, Page K. 2006. CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells. Respir Res 7:84-92.
31. Platz J, Beisswenger C, Dalpke A, Koczulla R, Pinkenburg O, Vogelmeier C, Bals R. 2004. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J Immunol 173:1219-1223.
32. Rankin R, Pontarollo R, Gomis S, Karvonen B, Willson P, Loehr BI, Godson DL, Babiuk LA, Hecker R, van Drunen Littel-van den Hurk S. 2002. CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 20:3014-3022.
33. Rankin R, Pontarollo R, Ioannou X, Krieg AM, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S. 2001. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 11:333-340.
34. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A. 2005. The evolution of vertebrate toll-like receptors. Proc Natl Acad Sci USA 102:9577-9582.
35. Roy SR, Schiltz AM, Marotta A, Shen Y, Liu AH. 2003. Bacterial DNA in house and farm barn dust. J Allergy Clin Immunol 112:571-578.
36. Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, Wagner H, Bauer S. 2004. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 34:2541-2550.
37. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi,A-K, Krieg AM. 1997. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract, J Clin Invest 100:68-73.
38. Schwartz DA, Wohlford-Lenane CL, Quinn TJ, Krieg AM. 1999. Bacterial DNA or oligonucleotides containing unmethylated cpg motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J Immunol 163:224-231.
39. Singh B, Pearce JW, Gamage LN, Janardhan K, Caldwell S. 2004. Depletion of pulmonary intravascular macrophages inhibits acute lung inflammation. Am J Physiol 286:L363-L372.
40. Singh SS, Janardhan SK, Parbhakar O, Caldwell S, Appleyard G, Singh B. 2006. Expression of Toll-like receptor 4 and 2 in horse lungs, Vet Res 37:541-551.
41. Staub NC. 1994. Pulmonary intravascular macrophages. Annu Rev Physiol. 56:47-67.
42. Suzuki K, Suda T, Naito T, Ide K, Chida K, Nakamura H. 2005. Impaired Toll-like Receptor 9 Expression in Alveolar Macrophages with No Sensitivity to CpG DNA. Am J Respir Crit Care Med 171:707-713.
43. Tran N, Koch A, Berkels R, Boehm O, Zacharowski PA, Baumgarten G, Knuefermann P, Schott M, Kanczkowski W, Bornstein SR, Lightman SL, Zacharowski K. 2007. Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J Clin Endocrin Metab 92:2773-2783.
44. Wong CK, Cheung PFY, Ip WK, Lam CWK. 2007. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 37: 85-96.
45. Yasuda H, Leelahavanickul A, Tsunoda S, Dear JW, Takahashi Y, Ito S, Hu X, Zhou H, Doi K, Childs R, Klinman DM, Yuen PS, Star RA. 2008. Chloroquine and inhibition of toll-like receptor 9 protects from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 294:F1050-F1058.
46. Yeo S-J, Yoon J-G, Hong S-C, Ae-Kyung Yi A-K. 2003. CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J Immunol 170:1052-1061.
47. Zhang YW, Davis EG, Blecha F, Wilkerson MJ. 2008. Molecular cloning and characterization of equine Toll-like receptor 9. Vet Immunol Immunopathol 124:209-219.
48. Zimmermann S, Dalpke A, Heeg K. 2008. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections. Int J Med Microbiol 298:39-44.